Northwest Investment Counselors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $156K | Buy |
+3,024
| New | +$156K | 0.04% | 161 |
|
|
2024
Q2 | – | Sell |
-2,995
| Closed | -$162K | – | 185 |
|
|
2024
Q1 | $162K | Buy |
+2,995
| New | +$162K | 0.04% | 150 |
|
|
2023
Q4 | – | Sell |
-3,380
| Closed | -$196K | – | 183 |
|
|
2023
Q3 | $196K | Buy |
3,380
+7
| +0.2% | +$406 | 0.05% | 152 |
|
|
2023
Q2 | $216K | Sell |
3,373
-191
| -5% | -$12.2K | 0.06% | 148 |
|
|
2023
Q1 | $247K | Buy |
3,564
+1,297
| +57% | +$89.9K | 0.07% | 142 |
|
|
2022
Q4 | $163K | Buy |
2,267
+396
| +21% | +$28.5K | 0.05% | 165 |
|
|
2022
Q3 | $133K | Hold |
1,871
| – | – | 0.04% | 158 |
|
|
2022
Q2 | $144K | Sell |
1,871
-8
| -0.4% | -$616 | 0.04% | 154 |
|
|
2022
Q1 | $137K | Buy |
1,879
+23
| +1% | +$1.68K | 0.04% | 156 |
|
|
2021
Q4 | $116K | Buy |
+1,856
| New | +$116K | 0.03% | 172 |
|
|
2021
Q2 | – | Sell |
-2,079
| Closed | -$131K | – | 182 |
|
|
2021
Q1 | $131K | Buy |
+2,079
| New | +$131K | 0.04% | 155 |
|
|
2020
Q4 | – | Sell |
-2,133
| Closed | -$129K | – | 178 |
|
|
2020
Q3 | $129K | Buy |
+2,133
| New | +$129K | 0.04% | 143 |
|
|
2019
Q4 | – | Sell |
-1,834
| Closed | -$93K | – | 186 |
|
|
2019
Q3 | $93K | Buy |
+1,834
| New | +$93K | 0.03% | 178 |
|
|
2017
Q4 | – | Sell |
-1,636
| Closed | -$104K | – | 158 |
|
|
2017
Q3 | $104K | Buy |
1,636
+2
| +0.1% | +$127 | 0.05% | 141 |
|
|
2017
Q2 | $91K | Buy |
+1,634
| New | +$91K | 0.04% | 141 |
|